Facilitating Follow-Up Adherence for Abnormal Pap Smears

NACompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Uterine Cervical Neoplasms
Interventions
BEHAVIORAL

Cognitive-affective barriers counseling

Culturally-relevant/sensitive barrier-specific messages drawn from a pre-developed library designed to counsel individuals regarding their specific barriers to adherence, e.g., by increasing risk-related knowledge, providing accurate outcome and self-efficacy expectancies, addressing health-related values and goals, moderating risk-related affect, or offering active plans and strategies to assist with self-regulation

BEHAVIORAL

Cognitive-affective barriers counseling via brochure

Culturally-relevant/sensitive barrier-specific messages drawn from a pre-developed library designed to counsel individuals regarding their specific barriers to adherence via brochure, e.g., by increasing risk-related knowledge, providing accurate outcome and self-efficacy expectancies, addressing health-related values and goals, moderating risk-related affect, or offering active plans and strategies to assist with self-regulation

BEHAVIORAL

standard care

Cognitive-affective barriers (CAB) assessment delivered via phone; receipt of a notification letter from physician regarding abnormal Pap test result, need to undergo colposcopy, appointment date and clinic contact numbers; telephone confirmation and post-card appointment reminder

Trial Locations (1)

19111

Fox Chase Cancer Center, Philadelphia

All Listed Sponsors
collaborator

Temple University

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

Fox Chase Cancer Center

OTHER

NCT01561326 - Facilitating Follow-Up Adherence for Abnormal Pap Smears | Biotech Hunter | Biotech Hunter